Recently, Foxtrot PTCA balloon dilatation catheter, independently developed by Shanghai MicroPort Medical (Group) Co., Ltd., received CE certificate from DEKRA Certification B.V. The product approval further signals the Company's globalization strategy.
Foxtrot PTCA balloon dilatation catheter is used for balloon dilatation of the stenotic portion of a coronary artery for the purpose of improving myocardial perfusion. It is also indicated for post-delivery expansion of balloon-expandable stents. Studies have shown that the degree of stent apposition in the lesion area is directly related to the pressure exerted on the balloon during the implant. Nowadays, it has become a common practice using high pressure balloon to increase the effectiveness and uniformed stent expansion.